Development of CELIAC-Q KIDS: A Patient-Reported Outcome Measure for Pediatric Celiac Disease
Key facts
- Who runs it
- McMaster University
- Where
- Canada2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 100 people, planned
- Started
- 26 Oct 2020
- Expected to end
- 31 Dec 2026
- Type of study
- Observational, 3 groups
- Treatments tested
- Interview and scale development
- Record updated
- 4 November 2022
Who can take part
- Age
- 4 years to 17 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Patients diagnosed with celiac disease
- Pediatric patients (18 years and younger)
- Ability to understand and communicate in the English language
Who cannot take part
- Patients who do not have celiac disease
- Non-pediatric patients (over 18)
- Unable to understand and communicate in the English language
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
A multicentre, prospective observational study to develop the CELIAC-Q KIDS patient reported outcome measure for children and adolescents with celiac disease. The CELIAC- Q KIDS will contain a comprehensive set of independently functioning scales designed to measure outcomes that matter to children with celiac disease, as well as scales to measure patients experience with the gluten-free diet.
The 3 groups in the trial
- Pediatric Patients
Pediatric patients with celiac disease.
Treatment: Interview and scale development
- Caregivers and parents
Caregivers and parents of pediatric patients with celiac disease
Treatment: Interview and scale development
- Experts
Group of experts in pediatric celiac disease to provide feedback on scale development.
Treatment: Interview and scale development
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Phase 1 Protocol to Develop a Patient-reported Outcome Measure for Children and Adolescents With Celiac Disease: CELIAC-Q KIDS
- Record updated
- 4 November 2022